Defendant
2 cases as defendant.
Solmetex, LLC is a privately held company headquartered in Northborough, Massachusetts, founded in 1994. The company is currently backed by several private equity firms, including GTCR, AGIC Capital, Avista Healthcare Partners, and Gemini Investors. Solmetex has an estimated annual revenue of $25.4 million and approximately 101-120 employees.
Solmetex provides dental water safety and waste compliance systems, as well as a variety of dental consumables and equipment. Their key product lines include amalgam separators like the NXT Hg5™ Series, which help dental practices comply with environmental regulations for mercury disposal. Through strategic acquisitions, Solmetex has expanded its offerings to include waterline treatment and testing solutions (Sterisil®), advanced dental isolation systems (DryShield®), and regenerative biomaterials (Impladent).
Solmetex's patent litigation posture indicates they are an operating company that defends against challenges to their intellectual property. They are listed as a defendant in one tracked case.
The notable case, Ascentcare Dental Products, Inc. v. Solmetex, LLC, is an inter partes review (IPR) proceeding at the Patent Trial and Appeal Board (PTAB), initiated by Ascentcare Dental Products, Inc. against Solmetex, LLC. This PTAB case challenges the validity of a Solmetex patent related to an intraoral device.
An Inter Partes Review (IPR) was filed by Ascentcare Dental Products Inc. against Solmetex LLC concerning patent 12290418. Although discretionary denial was deemed inappropriate, the case was ultimately not instituted procedurally by the PTAB.
A Post-Grant Review (PGR) proceeding initiated by Unified Patents, as the petitioner, against Solmetex LLC, the patent owner, concerning US patent 121679948. The PTAB decided not to proceed with the review for procedural reasons.